Awareness and knowledge of anal cancer in a community-recruited sample of HIV-negative and HIV-positive gay and bisexual men
Lance Feeney A , Mary Poynten B , Fengyi (Jeff) Jin B , Craig Cooper A , David J. Templeton B C D , Matthew R. O’Dwyer A , Andrew Grulich B and Richard J. Hillman E F
+ Author Affiliations
- Author Affiliations
A Positive Life NSW, Suite 5.2, Level 5, 414 Elizabeth Street, Surry Hills, NSW 2010, Australia.
B HIV Epidemiology and Prevention Program, The Kirby Institute, Level 6, Wallace Wurth Building, High Street, UNSW Sydney, Kensington, NSW 2052, Australia.
C RPA Sexual Health, 16 Marsden Street, Camperdown, NSW 2050, Australia.
D Sydney Medical School, University of Sydney, NSW 2006, Australia.
E HIV, Immunology & Infectious Diseases, St Vincent’s Hospital, 390 Victoria Street, Darlinghurst, NSW 2010, Australia.
F Corresponding author. Email: Richard.Hillman@unsw.edu.au
Sexual Health 16(3) 240-246 https://doi.org/10.1071/SH18219
Submitted: 20 August 2018 Accepted: 29 January 2019 Published: 10 May 2019
Abstract
Background: Anal cancer disproportionately affects people with HIV infection, especially gay and bisexual men (GBM). The awareness and understanding of human papillomavirus (HPV) and anal cancer in a community-based sample of people living with HIV and GBM was explored to inform future evidence-based public health interventions. Methods: Following consultation with affected communities and relevant healthcare professionals, a questionnaire was developed that assessed knowledge, understanding and experience of anal HPV, HPV vaccination, screening and perceived personal risk of anal cancer. Participants were recruited through HIV community and GBM organisations and anonymously completed the questionnaire online. Results: Of 1660 questionnaires returned, 1574 were analysed from men, of whom 1535 (97.5%) identified as GBM and 15.7% reported being HIV-positive. Most (51.8%) of the HIV-positive men and 68.1% of HIV-negative or unknown men thought their risk of anal cancer was the same, or lower, than that of the general population. Only a small minority (12.5%) reported ever having talked to their doctor about anal HPV and/or anal cancer and 11.6% reported ever having had an anal cancer examination. Less than one-third (31.5%) had heard of HPV vaccination and only 2.9% of men recollected receiving HPV vaccination. Conclusions: Knowledge and awareness of anal cancer was generally poor in a sample of HIV-positive and HIV-negative GBM. Specific information targeted at these people could potentially raise awareness, leading to earlier diagnosis, reduced burden of disease among GBM and less demands on the healthcare system. Young GBM might benefit from education regarding the importance of HPV vaccination.
Additional keywords: health promotion, HPV, symptoms.
References
[1] Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, Kirk GD, D’Souza G, Bosch RJ, Brooks JT, Napravnik S, Hessol NA, Jacobson LP, Kitahata MM, Klein MB, Moore RD, Rodriguez B, Rourke SB, Saag MS, Sterling TR, et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012; 54 1026–34.| Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America.Crossref | GoogleScholarGoogle Scholar | 22291097PubMed |
[2] Grulich AE, Poynten IM, Machalek DA, Jin F, Templeton DJ, Hillman RJ. The epidemiology of anal cancer. Sex Health 2012; 9 504–8.
| The epidemiology of anal cancer.Crossref | GoogleScholarGoogle Scholar | 22958581PubMed |
[3] Shiels MS, Pfeiffer RM, Chaturvedi AK, Kreimer AR, Engels EA. Impact of the HIV epidemic on the incidence rates of anal cancer in the United States. J Natl Cancer Inst 2012; 104 1591–8.
| Impact of the HIV epidemic on the incidence rates of anal cancer in the United States.Crossref | GoogleScholarGoogle Scholar | 23042932PubMed |
[4] Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, Quesenberry CP, Abrams DI, Silverberg M. Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS 2012; 26 2223–31.
| Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.Crossref | GoogleScholarGoogle Scholar | 22951631PubMed |
[5] Kang YJSM, Canfell K. Anal cancer in high-income countries: increasing burden of disease. PLoS One 2018; 13 e0205105
| Anal cancer in high-income countries: increasing burden of disease.Crossref | GoogleScholarGoogle Scholar |
[6] Read TR, Huson KL, Millar JL, Haydon A, Porter IW, Grulich AE, Hocking JS, Chen MY, Bradshaw CS, Fairley CK. Size of anal squamous cell carcinomas at diagnosis: a retrospective case series. Int J STD AIDS 2013; 24 879–82.
| Size of anal squamous cell carcinomas at diagnosis: a retrospective case series.Crossref | GoogleScholarGoogle Scholar | 23970608PubMed |
[7] Hillman RJ, Garland SM, Gunathilake MP, Stevens M, Kumaradevan N, Lemech C, Ward RL, Meagher A, McHugh L, Jin F, Carroll S, Goldstein D, Grulich AE, Tabrizi SN. Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers. Int J Cancer 2014; 135 996–1001.
| Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers.Crossref | GoogleScholarGoogle Scholar | 24497322PubMed |
[8] Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol 2018; 47 14–26.
| Epidemiology and burden of HPV-related disease.Crossref | GoogleScholarGoogle Scholar | 29037457PubMed |
[9] Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 2016; 4 e609–16.
| Global burden of cancers attributable to infections in 2012: a synthetic analysis.Crossref | GoogleScholarGoogle Scholar | 27470177PubMed |
[10] Drolet M, Bénard É, Boily M-C, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JML, Cummings T, Donovan B, Fairley CK, Flagg EW, Johnson AM, Kahn JA, Kavanagh K, Kjaer SK, Kliewer EV, Lemieux-Mellouki P, Markowitz L, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2015; 15 565–80.
| Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.Crossref | GoogleScholarGoogle Scholar | 25744474PubMed |
[11] Wilkin TJ, Chen H, Cespedes MS, Leon-Cruz JT, Godfrey C, Chiao EY, Bastow B, Webster-Cyriaque J, Feng Q, Dragavon J, Coombs RW, Presti RM, Saah A, Cranston RD. A randomized, placebo-controlled trial of the quadrivalent HPV vaccine in HIV-infected adults aged 27 years or older: AIDS Clinical Trials Group Protocol A5298. Clin Infect Dis 2018; 67 1339–46.
| 29659751PubMed |
[12] Australasian Society for HIV. Anal cancer in men living with HIV. Sydney: Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine; 2019. Available online at: https://www.ashm.org.au/HIV/hiv-management/anal-cancer/ [verified 8 March 2019].
[13] Ong JJ, Chen M, Grulich AE, Fairley CK. Regional and national guideline recommendations for digital ano-rectal examination as a means for anal cancer screening in HIV positive men who have sex with men: a systematic review. BMC Cancer 2014; 14 557
| Regional and national guideline recommendations for digital ano-rectal examination as a means for anal cancer screening in HIV positive men who have sex with men: a systematic review.Crossref | GoogleScholarGoogle Scholar | 25081485PubMed |
[14] Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D. Anal cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Radiother Oncol 2014; 111 330–9.
| Anal cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.Crossref | GoogleScholarGoogle Scholar | 24947004PubMed |
[15] Machalek DA, Grulich AE, Hillman RJ, Jin F, Templeton DJ, Tabrizi SN, Garland SM, Prestage G, McCaffery K, Howard K, Tong W, Fairley CK, Roberts J, Farnsworth A, Poynten IM, SPANC Study Team. The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study. BMC Public Health 2013; 13 946
| The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study.Crossref | GoogleScholarGoogle Scholar | 24107134PubMed |
[16] United Nations Human Rights Office of the High Commissioner. Fact sheet: intersex. Geneva: Office of the United Nations High Commissioner for Human Rights; 2018. Available online at: https://unfe.org/system/unfe-65-Intersex_Factsheet_ENGLISH.pdf [verified 7 March 2019].
[17] Bjekic M, Sipetic-Grujicic S, Dunic I, Salemovic D, Vlajinac H. Human papillomavirus and anal carcinoma knowledge in men who have sex with men in Belgrade, Serbia. Int J Dermatol 2016; 55 1082–7.
| Human papillomavirus and anal carcinoma knowledge in men who have sex with men in Belgrade, Serbia.Crossref | GoogleScholarGoogle Scholar | 27260829PubMed |
[18] Osazuwa-Peters N, Adjei Boakye E, Mohammed KA, Tobo BB, Geneus CJ, Schootman M. Not just a woman’s business! Understanding men and women’s knowledge of HPV, the HPV vaccine, and HPV-associated cancers. Prev Med 2017; 99 299–304.
| Not just a woman’s business! Understanding men and women’s knowledge of HPV, the HPV vaccine, and HPV-associated cancers.Crossref | GoogleScholarGoogle Scholar | 28341458PubMed |
[19] Australian Institute of Health and Welfare. Australian Cancer Incidence and Mortality (ACIM) books. Canberra: AIHW; 2017. Available online at: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/acim-books [verified 17 April 2019].
[20] Sauter M, Keilholz G, Kranzbühler H, Lombriser N, Prakash M, Vavricka SR, Misselwitz B. Presenting symptoms predict local staging of anal cancer: a retrospective analysis of 86 patients. BMC Gastroenterol 2016; 16 46
| Presenting symptoms predict local staging of anal cancer: a retrospective analysis of 86 patients.Crossref | GoogleScholarGoogle Scholar | 27048435PubMed |
[21] Tinmouth J, Peeva V, Amare H, Blitz S, Raboud J, Sano M, Steele L, Salit IE. Progression from perianal high-grade anal intraepithelial neoplasia to anal cancer in HIV-positive men who have sex with men. Dis Colon Rectum 2016; 59 836–42.
| Progression from perianal high-grade anal intraepithelial neoplasia to anal cancer in HIV-positive men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 27505112PubMed |
[22] Koskan AM, LeBlanc N, Rosa-Cunha I. Exploring the perceptions of anal cancer screening and behaviors among gay and bisexual men infected with HIV. Cancer Control 2016; 23 52–8.
| Exploring the perceptions of anal cancer screening and behaviors among gay and bisexual men infected with HIV.Crossref | GoogleScholarGoogle Scholar | 27009457PubMed |
[23] Ka‘opua LSI, Cassel K, Shiramizu B, Stotzer RL, Robles A, Kapua C, Orton M, Milne C, Sesepasara M. Addressing risk and reluctance at the nexus of HIV and anal cancer screening. Health Promot Pract 2016; 17 21–30.
| Addressing risk and reluctance at the nexus of HIV and anal cancer screening.Crossref | GoogleScholarGoogle Scholar |
[24] Ong JJ, Temple-Smith M, Chen M, Walker S, Grulich A, Hoy J, Fairley CK. Why are we not screening for anal cancer routinely - HIV physicians’ perspectives on anal cancer and its screening in HIV-positive men who have sex with men: a qualitative study. BMC Public Health 2015; 15 67
| Why are we not screening for anal cancer routinely - HIV physicians’ perspectives on anal cancer and its screening in HIV-positive men who have sex with men: a qualitative study.Crossref | GoogleScholarGoogle Scholar | 25636181PubMed |
[25] Palefsky JM, Giuliano AR, Goldstone S, Moreira ED, Aranda C, Jessen H, Hillman R, Ferris D, Coutlee F, Stoler MH, Marshall JB, Radley D, Vuocolo S, Haupt RM, Guris D, Garner EIO. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365 1576–85.
| HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.Crossref | GoogleScholarGoogle Scholar | 22029979PubMed |
[26] Nadarzynski T, Smith H, Richardson D, Pollard A, Llewellyn C. Perceptions of HPV and attitudes towards HPV vaccination amongst men who have sex with men: a qualitative analysis. Br J Health Psychol 2017; 22 345–61.
| Perceptions of HPV and attitudes towards HPV vaccination amongst men who have sex with men: a qualitative analysis.Crossref | GoogleScholarGoogle Scholar | 28191723PubMed |
[27] Poon MKL, Wong JPH, Li ATW, Manuba M, Bisignano A, Owino M, Vahabi M. HIV-positive MSM’s knowledge of HPV and anal cancer self-sampling: a scoping review. Curr Oncol 2018; 25 e83–e89.
| HIV-positive MSM’s knowledge of HPV and anal cancer self-sampling: a scoping review.Crossref | GoogleScholarGoogle Scholar | 29507499PubMed |
[28] Battaglia TA, Gunn CM, McCoy ME, Mu HH, Baranoski AS, Chiao EY, Kachnic LA, Stier EA. Beliefs about anal cancer among HIV-infected women: barriers and motivators to participation in research. Women’s Health Issues 2015; 25 720–6.
| Beliefs about anal cancer among HIV-infected women: barriers and motivators to participation in research.Crossref | GoogleScholarGoogle Scholar | 26253825PubMed |
[29] Ong JJ, Fairley CK, Carroll S, Walker S, Chen M, Read T, Grulich A, Bradshaw C, Kaldor J, Clarke P. Cost-effectiveness of screening for anal cancer using regular digital ano-rectal examinations in men who have sex with men living with HIV. J Int AIDS Soc 2016; 19 20514
| Cost-effectiveness of screening for anal cancer using regular digital ano-rectal examinations in men who have sex with men living with HIV.Crossref | GoogleScholarGoogle Scholar | 26942721PubMed |
